Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Phase Biomarkers”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT00774137
What this trial is testing

Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery

Who this might be right for
Kidney Failure, AcuteRenal Insufficiency
Yale University 1,550
Large-scale testing (Phase 3)Active Not RecruitingNCT05544656
What this trial is testing

The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain and Sciatic Pain "BETA"

Who this might be right for
Low Back Pain
Semmelweis University 150
Early research (Phase 1)Study completedNCT03298984
What this trial is testing

Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).

Who this might be right for
Acute Myeloid Leukemia
Sumitomo Pharma America, Inc. 32
Not applicableStudy completedNCT05569499
What this trial is testing

Hematocrit Evolution in Severe Burns

Who this might be right for
Severe Skin Burns
Centre Hospitalier Régional Metz-Thionville 230
Testing effectiveness (Phase 2)Study completedNCT02806947
What this trial is testing

Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Who this might be right for
Acute GVHD
Medical College of Wisconsin 127
Testing effectiveness (Phase 2)Ended earlyNCT02520011
What this trial is testing

Alvocidib Biomarker-driven Phase 2 AML Study

Who this might be right for
Acute Myeloid Leukemia
Sumitomo Pharma America, Inc. 104
Not applicableLooking for participantsNCT03348761
What this trial is testing

RTMS Response Trajectories in Depression

Who this might be right for
Depression
Chinese University of Hong Kong 70
Not applicableStudy completedNCT03651635
What this trial is testing

MR-proADM and CT-proET-1 During ICU Treatment

Who this might be right for
Acute Phase BiomarkersMedical ICU Admitted Patients
University of Zurich 533
Not applicableUnknownNCT04957888
What this trial is testing

Microbial Markers for AGI

Who this might be right for
Acute Gastrointestinal Injury
Peking University Third Hospital 584
Not applicableStudy completedNCT07163988
What this trial is testing

Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I

Who this might be right for
Acute Myocardial Infarction (AMI)
Indiana University 312
Not applicableStudy completedNCT02940145
What this trial is testing

Phase Angle and Body Composition, Inflammatory and Oxidative Stress Biomarkers.

Who this might be right for
Body Composition, BeneficialOxidative StressAcute and Chronic Inflammation
Universidade Estadual de Londrina 51
Not applicableStudy completedNCT01884649
What this trial is testing

Fetuin A in Hashimoto Thyroiditis

Who this might be right for
Hashimoto Thyroiditis
Istanbul Medeniyet University 97
Not applicableActive Not RecruitingNCT04741464
What this trial is testing

Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis

Who this might be right for
Deep Vein ThrombosisInflammatory Response
Centre Hospitalier Universitaire, Amiens 9
Testing effectiveness (Phase 2)Looking for participantsNCT03684278
What this trial is testing

Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)

Who this might be right for
Acute Pancreatitis
University of Liverpool 290
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Not applicableStudy completedNCT00859300
What this trial is testing

MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction

Who this might be right for
Myocardial Infarction
Hospices Civils de Lyon 1,011
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableUnknownNCT05111379
What this trial is testing

Acute Local Metabolomic Alterations in Blood and Muscle Tissue in Intermittent Claudication

Who this might be right for
Peripheral Arterial Occlusive Disease Fontaine Stage IIa
University of Tartu 40
Not applicableWithdrawnNCT03843008
What this trial is testing

Melatonin in Acute Stroke

Who this might be right for
Stroke, AcuteIschemic Stroke
University of Florida
Not applicableEnded earlyNCT04434209
What this trial is testing

A Study Looking At the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients with Sepsis (Limiting AKI Progression in Sepsis)

Who this might be right for
SepsisAcute Kidney InjurySeptic Shock
BioMérieux 19
Load More Results